TCL Archive Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday July 6, 2012
TCL Archive Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS January 24, 2014
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
